G. Davı̀

Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis
201824 citationsauthor #6
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study
201816 citationsauthor #8
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study
20181 citationsauthor #8
2210PCSK9 beyond its role in cholesterol homeostasis: co-activator of platelet function
20171 citationsauthor #7
Italian intersociety consensus on DOAC use in internal medicine
201747 citationsauthor #5
Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study.
201724 citationsauthor #8
Platelets and Diabetes
20171 citationsauthor #4
Coronary artery disease and proprotein convertase subtilisin/kexin 9: A new platelet activator
20170 citationsauthor #7
Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach.
201765 citationsauthor #4
A new role for PCSK9 as a co-activator of platelet reactivity.
20171 citationsauthor #7
Circulating biomarkers : the platelet releasate and the platelet sheddome
20170 citationsauthor #6
Oxidant stress as a major determinant of platelet activation in invasive breast cancer
201726 citationsauthor #10
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes
201793 citationsauthor #13
Oxidative Stress Modulation Through Habitual Physical Activity.
201661 citationsauthor #3
OC.02.4 OXIDATIVE STRESS AND THROMBOXANE-DEPENDENT PLATELET ACTIVATION IN INFLAMMATORY BOWEL DISEASE (IBD): EFFECTS OF ANTI-TNF-ALFA TREATMENT
20160 citationsauthor #16
Microparticles as new markers of cardiovascular risk in diabetes and beyond
201681 citationsauthor #6
The deadly line linking sympathetic overdrive, dipping status and vascular risk: critical appraisal and therapeutic implications
20166 citationsauthor #4
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective.
201670 citationsauthor #2
High serum CXCL10 in Rickettsia conorii infection is endothelial cell mediated subsequent to whole blood activation.
20163 citationsauthor #5
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment
201627 citationsauthor #15
Aspirin, platelets, and cancer: The point of view of the internist.
201638 citationsauthor #3
Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus
201653 citationsauthor #9
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding.
201614 citationsauthor #11
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease.
201615 citationsauthor #9
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease.
201612 citationsauthor #10
P hromboxane-Dependent CD 40 igand Release in Type 2 Diabetes Mellitus
20160 citationsauthor #2
The left atrial appendage: from embryology to prevention of thromboembolism
201673 citationsauthor #16
Platelet-associated tissue factor as a new mechanism involved in the prothrombotic phenotype of stable angina patients with type-2 diabetes mellitus (T2DM)
20160 citationsauthor #6
Ankle-Brachial Index and cardiovascular events in atrial fibrillation
201631 citationsauthor #2
The Coxib case: Are EP receptors really guilty?
201611 citationsauthor #3
Coagulation at the crossroads of the communicable/non‐communicable disease dyad: The case of pneumonia
20163 citationsauthor #3
Arterial stiffness and sedentary lifestyle: Role of oxidative stress.
201667 citationsauthor #8
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro
201653 citationsauthor #19
Severe non-traumatic bleeding, the answer is not in the blood
20153 citationsauthor #7
Oxidative stress in chronic vascular disease: From prediction to prevention.
2015131 citationsauthor #3
Sulodexide for the Prevention of Recurrent Venous Thromboembolism
2015100 citationsauthor #3
Coagulation and infective endocarditis: sooner or later
20156 citationsauthor #3
Correlation between Migraine Severity and Cholesterol Levels
201550 citationsauthor #6
Platelets and diabetes mellitus.
201574 citationsauthor #4
Thromboxane-dependent platelet activation after gastric banding for obesity.
20153 citationsauthor #5
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type.
201535 citationsauthor #9
Abstract 15529: Aspirin and Renal Insufficiency Progression in Patients With Atrial Fibrillation and Chronic Kidney Disease
20150 citationsauthor #9
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.
201557 citationsauthor #4
Aspirin for primary prevention in diabetes mellitus: from the calculation of cardiovascular risk and risk/benefit profile to personalised treatment
201526 citationsauthor #4
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome.
201533 citationsauthor #13
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy
201424 citationsauthor #7
Folliculotropic mycosis fungoides with extreme pilosebaceous involvement and hematological abnormalities
20140 citationsauthor #7
Abstract 17186: In Vivo Platelet Activation in Impaired Glucose Tolerance and During Progression of Type 2 Diabetes: a Cross-sectional and Longitudinal Study
20142 citationsauthor #2
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study
201429 citationsauthor #8
Circulating Dickkopf‐1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low‐Dose Aspirin
201467 citationsauthor #10
Ankle-Brachial Index in Patients With Nonvalvular Atrial Fibrillation
20143 citationsauthor #2
MicroRNA-181b Regulates ALX/FPR2 Receptor Expression and Proresolution Signaling in Human Macrophages*
201443 citationsauthor #6
Heart failure and chronic kidney disease in a registry of internal medicine wards
20142 citationsauthor #173
Erratum to: Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study
20141 citationsauthor #8
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis
201413 citationsauthor #7
Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy.
20147 citationsauthor #7
Abstract 19927: Over-Treatment with Oral Anticoagulants of Non Valvular Atrial Fibrillation Patients at Low Risk of Stroke: The ARAPACIS Study
20140 citationsauthor #7
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper.
201496 citationsauthor #8
Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection
20148 citationsauthor #4
Circulating Myeloid‐Related Protein–8/14 is Related to Thromboxane‐Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low‐Dose Aspirin Treatment
201429 citationsauthor #10
Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation.
201326 citationsauthor #8
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy.
201359 citationsauthor #2
Chapter 35 – Diabetes Mellitus
20133 citationsauthor #1
P058 In vivo formation of 8-iso-prostaglandin F2 α and platelet activation in inflammatory bowel disease
20130 citationsauthor #11
Effects of high-amount–high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis
201341 citationsauthor #10
P.03.5 IN VIVO FORMATION OF 8-ISO-PROSTAGLANDIN F2A AND PLATELET ACTIVATION IN INFLAMMATORY BOWEL DISEASE
20130 citationsauthor #9
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low‐HDL Phenotype
201332 citationsauthor #10
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction.
201259 citationsauthor #8
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients.
201266 citationsauthor #9
Obesity-driven inflammation and colorectal cancer.
201241 citationsauthor #6
Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic Opportunities
201269 citationsauthor #6
Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress.
201248 citationsauthor #8
Abstract 194: Determinants of Platelet Activation in Chronic Kidney Disease
20120 citationsauthor #8
A Complex Interaction between Rickettsia conorii and Dickkopf-1 – Potential Role in Immune Evasion Mechanisms in Endothelial Cells
201216 citationsauthor #3
Growth and dewetting of gold on Si(1 1 1) investigated in situ by grazing incidence small angle x-ray scattering
20129 citationsauthor #3
Platelets, oxidative stress and preservation of the vascular endothelium: is it a matter of fat?
20122 citationsauthor #1
C0370 Plasma levels of soluble CD36, platelet activation, inflammation and oxidative stress are increased in type 2 diabetic patients
20120 citationsauthor #9
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes
2012224 citationsauthor #19
Diabetes mellitus and thrombosis.
2012233 citationsauthor #4
Biomarkers of platelet activation in acute coronary syndromes
201294 citationsauthor #6
Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism
201218 citationsauthor #10
Cardiovascular risk and dietary sugar intake: is the link so sweet?
201222 citationsauthor #4
Variability in the response to antiplatelet treatment in diabetes mellitus.
201210 citationsauthor #1
Beyond Hyperglycemia in Diabetes: Role of Statin Treatment on Thrombogenesis Triggered by Inflammation
20124 citationsauthor #2
Platelet activation in obesity and metabolic syndrome
2012240 citationsauthor #5
Thromboxane receptors antagonists and/or synthase inhibitors.
201258 citationsauthor #1
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects
201125 citationsauthor #7
Determinants of increased cardiovascular disease in obesity and metabolic syndrome.
201157 citationsauthor #5
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.
201182 citationsauthor #12
Abstract 9493: Plasma Levels Of Soluble CD36 In Type 2 Diabetes - A Link Between Platelet Activation, Inflammation And Oxidative Stress
20110 citationsauthor #1
TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus
201127 citationsauthor #3
Abstract 12997: Circulating MRP 8/14 is Associated with Thromboxane-Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment
20110 citationsauthor #9
Plasma Levels of Soluble CD36 in Type 2 Diabetes - A Link between Platelet Activation, Inflammation and Oxidative Stress
20110 citationsauthor #1
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy.
2010110 citationsauthor #12
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes.
20106 citationsauthor #16
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response
201084 citationsauthor #20
Aspirin as antiplatelet agent in diabetes. PROS-.
201010 citationsauthor #1
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress.
201020 citationsauthor #9
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment
201025 citationsauthor #2
Nutritional Interventions Targeting the Pathogenesis of Diabetes Mellitus , Metabolic Syndrome , and their Complications Antioxidant Vitamins
20100 citationsauthor #1

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT